Sivia Capital Partners’s Novo Nordisk NVO Stock Holding History

Sivia Capital Partners’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$283K	Sell	5,910 -1,032	-15%	-$44.3K	0.03%	463
2026 Q1	$255K	Sell	6,942 -16	-0.2%	-$758	0.05%	383
2025 Q4	$354K	Buy	6,958 +1,327	+24%	+$67.9K	0.07%	363
2025 Q3	$312K	Sell	5,631 -4,689	-45%	-$274K	0.09%	310
2025 Q2	$712K	Buy	10,320 +1,587	+18%	+$108K	0.24%	70
2025 Q1	$606K	Buy	8,733 +784	+10%	+$64.8K	0.28%	50
2024 Q4	$684K	Sell	7,949 -978	-11%	-$106K	0.34%	37
2024 Q3	$1.06M	Sell	8,927 -297	-3%	-$39.6K	0.63%	25
2024 Q2	$1.32M	Buy	9,224 +775	+9%	+$103K	0.88%	21
2024 Q1	$1.08M	Sell	8,449 -54	-0.6%	-$6.43K	0.74%	22
2023 Q4	$880K	Buy	+8,503	New	+$841K	0.67%	23

Other funds holding NVO

SRIM

Saratoga Research & Investment Management Saratoga, California $1.83B AUM 18.41% 1-Year Est. Return

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return

QV Investors Calgary, Alberta, Canada $1.3B AUM 31.14% 1-Year Est. Return

ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return

OFA

Oak Family Advisors Chicago, Illinois $391M AUM 26.35% 1-Year Est. Return

Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return

PFS

Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

AIP

ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return

Sivia Capital Partners's NVO Position: Q2 2026 in Review

Sivia Capital Partners reduced its Novo Nordisk (NVO) stake by 15% in Q2 2026, selling an estimated $44.3K and leaving 5,910 shares worth $283K. The position accounts for 0.03% of the portfolio, ranked #463.

Sivia Capital Partners first reported a position in NVO in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.32M in Q2 2024. 353 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

Sivia Capital Partners held 5,910 shares of Novo Nordisk worth $283K as of Q2 2026.
Sivia Capital Partners sold 1,032 Novo Nordisk shares in Q2 2026, an estimated $44.3K.
Novo Nordisk made up 0.03% of Sivia Capital Partners's portfolio in Q2 2026, its #463 holding.
Sivia Capital Partners first reported a position in Novo Nordisk in Q4 2023 and has held it in 11 quarters since.
Sivia Capital Partners's Novo Nordisk position peaked at $1.32M in Q2 2024.
353 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Sivia Capital Partners's 13F filing for Q2 2026, filed 23 Jul 2026.